Technology-based assessment of motor impairment in de novo Parkinson’s disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes
Objective: 1. To study motor functions in de novo drug-free Parkinson's disease (PD) patients and healthy controls (HC) and find an algorithm able to distinguish…Correlation of P300 parameters with cognition and impulse control disorders in patients with idiopathic Parkinson’s disease
Objective: To evaluate prevalence of impulse control disorders in patients with Parkinson's disease(PD), assess P300 latencies and look for any correlation between P300 latencies and…Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience
Objective: To describe characteristics of patients with secondary limb dystonia in Parkinson’s Disease, types of dystonia observed, and treatment/response with chemodenervation. Background: Dystonia can be…Fatigue in Parkinson’s disease and its relation with disease duration and treatment
Objective: Identify the presence of fatigue in a population of PD patients, establishing its association with disease duration and treatment. Background: Fatigue is one of…Frequency, course and predictors of fatigue in Parkinson’s disease patients and population-based controls
Objective: To assess fatigue frequency, course, and predictors in a large and diverse cohort of Parkinson’s disease (PD) patients and controls. Background: Fatigue is a…Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia
Objective: We investigated neuroanatomical differences between Parkinson’s disease (PD) patients with and without semantic fluency impairment and explored predictive markers for dementia development. Background: Sematic…Gut microbiota in Parkinson disease with mild cognition impairment in a southern Chinese cohort.
Objective: The aim of this study was to compare the structure of gut microbiota and short-chain fatty acid(SCFAs) in PD with mild cognitive impairment (PD-MCI),…RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.
Objective: To investigate the role of RNA binding protein Elavl in Parkinson’s disease related adaptive changes in the striatal transcriptome. Background: Elav-like (Elavl or Hu)…Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification
Objective: The aim of this work was to identify proteomic profiles associated with specific Parkinson’s disease (PD) clinical groups in leukocytes of patients from Rio…Prevalence of advanced Parkinson’s Disease in patients treated in the hospitals of the Spanish public health care system: PARADISE Study (interim analysis)
Objective: To determine the annual prevalence of patients with advanced Parkinson’s disease (APD) in patients diagnosed of Parkinson’s disease (PD) in the hospitals of the…
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 405
- Next Page »